ArticleThe oncologist2024

A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study.

Hui-Jen Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.